Marijuana Infused Chewing Gum May Now Be Able To Treat Crippling Bowel Issues And Stomach Cramps
A study suggests that a chewing gum laced in cannabis can cure irritable bowel syndrome, reducing painful stomach cramps, control bloating and normalise stool
More encouraging news for the devout pothead. A recent study discovered that chewing gum laced with marijuana can cure irritable bowel syndrome, reduce painful stomach cramps, control abdominal bloating, and normalise your stool. That's quite a handful for a dash of cannabis.
The reason? Researchers from Wageningen university in Netherlands claim that a key element in marijuana, CBD, could potentially ease colon spasms that are the cause of the symptoms related to colon spasms in the first place.
berkeleywellness/representational image
¡®We are excited to see that Axim Biotechnologies Inc (AXIM) has reached another milestone in its clinical development program,¡¯ said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. ¡®This is the first advancement in cannabinoid research for treatment of IBS in medical history and gives a clear example of how far ahead AXIM is in its clinical development programs,¡¯ Titus added.
The study claims itself to be first of its kind to test a relationship between CBD and IBS. From next month, the trial will begin, testing a cannabis-infused chewing gum made by US firm Medical Marijuana Inc. They will give the trial to 40 participants, aged between 18 and 65, alongside matching placebo gums.
cannabislifenetwork.com
The gum will contain 50mg of CBD per serving, and the participants will be allowed up to six chewing gums a day to control their stomach cramps, bloating, pain and other symptoms. Preliminary research suggests the product could reduce painful stomach cramps, control bloating, and normalise stool.
Mercola/representational image
¡®The cost to society concerning direct medical expenses and indirect costs associated with loss of productivity and work absenteeism tied to IBS is considerable,¡¯ Dr Titus stated. The study reveals that the drug would interact with the endogenous cannabinoid receptors in sufferers¡¯ digestive tract, loosening the tension. Specifically, it will test a new product called CanChew, developed my AXIM Biotechnologies, Medical Marijuana Inc¡¯s major investment company.
